Search

everythinglearnresearchcommunity

for

Search:↓

Ectodin integrates BMP, SHH, and FGF signals in developing ectodermal organs.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

PRP injections improve hair thickness for baldness.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

TNF family proteins are crucial for the development of skin features like hair, teeth, and mammary glands.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Some chemotherapy can cause permanent hair loss.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Hair thinning and loss in a girl with a rare metabolic disorder was linked to her condition.